Last update 21 Nov 2024

NGI-226

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms-
Target-
Mechanism-
Therapeutic Areas
Nervous System DiseasesSkin and Musculoskeletal DiseasesOther Diseases
Active Indication
Achilles tendinitisTendinopathy
Inactive Indication-
Originator Organization
Novartis AGNovartis AG
Active Organization
Novartis AGNovartis AGNovartis Pharmaceuticals Corp.Novartis Pharmaceuticals Corp.
Inactive Organization-
Drug Highest PhasePhase 2
First Approval Date-
Regulation-
Login to view timeline

Related

2
Clinical Trials associated with NGI-226
CTIS2022-500863-10-00 / Recruiting
A two part, randomized, participant and investigator-blinded, 2-arm, parallel-design, placebo-controlled study to evaluate the safety, tolerability and preliminary efficacy of NGI226 microparticles on tendon regeneration in patients with Achilles tendinopathy - CNGI226A12201
NCT05592990 / RecruitingPhase 2
A Two Part, Randomized, Participant and Investigator-blinded, 2-arm, Parallel-design, Placebo-controlled Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of NGI226 Microparticles on Tendon Regeneration in Patients With Achilles Tendinopathy
100 Clinical Results associated with NGI-226
Login to view more data
100 Translational Medicine associated with NGI-226
Login to view more data
100 Patents (Medical) associated with NGI-226
Login to view more data
100 Deals associated with NGI-226
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Achilles tendinitisPhase 2
GB
Novartis Pharmaceuticals Corp.Novartis Pharmaceuticals Corp.
14 Jun 2023
Achilles tendinitisPhase 2
US
Novartis Pharmaceuticals Corp.Novartis Pharmaceuticals Corp.
14 Jun 2023
Achilles tendinitisPhase 2
FR
Novartis Pharmaceuticals Corp.Novartis Pharmaceuticals Corp.
14 Jun 2023
Achilles tendinitisPhase 2
DE
Novartis Pharmaceuticals Corp.Novartis Pharmaceuticals Corp.
14 Jun 2023
TendinopathyPhase 2
US
Novartis AGNovartis AG
-
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free